tiprankstipranks
Palisade Bio (PALI)
NASDAQ:PALI
US Market

Palisade Bio (PALI) Financial Statements

Compare
516 Followers

Palisade Bio Financial Overview

Palisade Bio's market cap is currently $2.29M. The company's EPS TTM is $-15.044; its P/E ratio is ―; Palisade Bio is scheduled to report earnings on March 14, 2025, and the estimated EPS forecast is $-2.58. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue$ 250.00K$ 0.00$ 0.00$ 13.52K$ 15.39K
Gross Profit$ 250.00K$ -167.00K$ -168.00K$ -132.48K$ 15.39K
Operating Income$ -13.07M$ -15.72M$ -41.85M$ -9.30M$ -8.63M
EBITDA$ -12.28M$ -15.31M$ -24.05M$ -9.94M$ -8.20M
Net Income$ -12.30M$ -12.80M$ -27.27M$ -10.57M$ -8.35M
Balance Sheet
Cash & Short-Term Investments$ 12.43M$ 12.38M$ 10.49M$ 713.00K$ 5.11M
Total Assets$ 14.05M$ 15.76M$ 12.51M$ 3.02M$ 6.58M
Total Debt$ 369.00K$ 404.00K$ 199.00K$ 1.42M$ 180.91K
Net Debt$ -12.06M$ -11.98M$ -10.30M$ 708.00K$ -4.93M
Total Liabilities$ 2.74M$ 3.28M$ 5.15M$ 19.62M$ 1.46M
Stockholders' Equity$ 11.31M$ 12.48M$ 7.37M$ -16.60M$ 5.13M
Cash Flow
Free Cash Flow$ -11.14M$ -13.37M$ -14.77M$ -4.77M$ -7.26M
Operating Cash Flow$ -11.13M$ -13.36M$ -14.77M$ -4.77M$ -7.26M
Investing Cash Flow$ -4.00K$ -10.00K$ -54.00K$ -6.00K$ 3.92M
Financing Cash Flow$ 11.19M$ 15.26M$ 24.61M$ 1.89M$ 6.59M
Currency in USD

Palisade Bio Earnings and Revenue History

Palisade Bio Debt to Assets

Palisade Bio Cash Flow

Palisade Bio Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis